Pompe in the Press (The Courier-Mail, Australia): “…The medication, called Myozyme, is not expected to be included in the Pharmaceutical Benefits Scheme funding when an announcement is made on December 17. But Mr Wheller and 19 other Pompe sufferers in Australia are concerned the Federal Government is putting their lives at risk and are incensed that products such as nicotine patches do qualify for funding…”
- Read the article online (The Courier-Mail, Australia)